Lemaitre Vascular(LMAT)
$76.10-0.91 (-1.18%)
LMAT
Lemaitre Vascular financials statements
$76.10
At close:-0.91 (-1.18%)
Want to see LMAT full AI Analyst Report?
Lemaitre Vascular (LMAT) Ratios
232 Followers
Lemaitre Vascular Ratios
LMAT's free cash flow for Q3 2026 was $19.66M. For the 2026 fiscal year, LMAT's free cash flow was decreased by $-2.33M and operating cash flow was $21.99M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 12.89 | 13.14 | 6.51 | 6.39 | 6.41 |
| Quick Ratio | 10.95 | 11.31 | 4.76 | 4.60 | 4.55 |
| Cash Ratio | 0.78 | 0.84 | 0.81 | 0.76 | 0.64 |
| Solvency Ratio | 0.31 | 0.25 | 0.81 | 0.71 | 0.94 |
| Operating Cash Flow Ratio | 2.24 | 1.44 | 1.23 | 1.00 | 1.61 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 246.06M | $ 187.66M | $ 145.72M | $ 119.46M | $ 101.23M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.30 | 0.34 | 0.06 | 0.05 | 0.05 |
| Debt-to-Equity Ratio | 0.47 | 0.55 | 0.06 | 0.06 | 0.06 |
| Debt-to-Capital Ratio | 0.32 | 0.36 | 0.06 | 0.06 | 0.06 |
| Long-Term Debt-to-Capital Ratio | 0.30 | 0.33 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.56 | 1.64 | 1.16 | 1.16 | 1.15 |
| Debt Service Coverage Ratio | 14.15 | 262.99 | 0.00 | 0.00 | 17.40 |
| Interest Coverage Ratio | 13.10 | 254.91 | 0.00 | 0.00 | 16.42 |
| Debt to Market Cap | 0.09 | 0.08 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 8.43 | 8.28 | 0.86 | 0.76 | 0.86 |
| Net Debt to EBITDA | 1.73 | 2.40 | -0.11 | -0.07 | 0.05 |
| Profitability Margins | |||||
| Gross Profit Margin | 71.53% | 68.63% | 65.66% | 64.89% | 65.65% |
| EBIT Margin | 32.20% | 25.96% | 20.40% | 17.01% | 23.64% |
| EBITDA Margin | 36.37% | 30.36% | 25.32% | 22.84% | 29.78% |
| Operating Profit Margin | 27.21% | 23.77% | 18.97% | 16.60% | 23.59% |
| Pretax Profit Margin | 30.12% | 25.87% | 20.40% | 17.01% | 22.20% |
| Net Profit Margin | 23.13% | 20.03% | 15.56% | 12.77% | 17.42% |
| Continuous Operations Profit Margin | 23.13% | 20.03% | 15.56% | 12.77% | 17.42% |
| Net Income Per EBT | 76.79% | 77.43% | 76.26% | 75.07% | 78.48% |
| EBT Per EBIT | 110.71% | 108.84% | 107.53% | 102.46% | 94.13% |
| Return on Assets (ROA) | 9.38% | 7.98% | 8.68% | 6.65% | 9.19% |
| Return on Equity (ROE) | 14.67% | 13.06% | 10.11% | 7.69% | 10.59% |
| Return on Capital Employed (ROCE) | 11.72% | 10.03% | 11.58% | 9.41% | 13.44% |
| Return on Invested Capital (ROIC) | 8.96% | 7.72% | 8.77% | 7.02% | 10.48% |
| Return on Tangible Assets | 11.17% | 9.79% | 12.59% | 10.42% | 15.45% |
| Earnings Yield | 3.14% | 2.13% | 2.39% | 2.04% | 2.53% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.43 | 7.31 | 7.72 | 7.33 | 7.87 |
| Payables Turnover | 19.49 | 39.16 | 17.79 | 19.55 | 22.67 |
| Inventory Turnover | 1.01 | 1.23 | 1.27 | 1.25 | 1.30 |
| Fixed Asset Turnover | 5.84 | 5.29 | 4.86 | 4.82 | 4.81 |
| Asset Turnover | 0.41 | 0.40 | 0.56 | 0.52 | 0.53 |
| Working Capital Turnover Ratio | 0.62 | 0.82 | 1.29 | 1.27 | 1.65 |
| Cash Conversion Cycle | 392.13 | 336.68 | 314.29 | 322.29 | 310.00 |
| Days of Sales Outstanding | 49.15 | 49.91 | 47.28 | 49.77 | 46.40 |
| Days of Inventory Outstanding | 361.71 | 296.09 | 287.52 | 291.20 | 279.71 |
| Days of Payables Outstanding | 18.73 | 9.32 | 20.51 | 18.67 | 16.10 |
| Operating Cycle | 410.86 | 346.00 | 334.80 | 340.96 | 326.11 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 3.59 | 1.97 | 1.65 | 1.15 | 1.66 |
| Free Cash Flow Per Share | 3.29 | 1.66 | 1.33 | 1.01 | 1.43 |
| Dividend Paid and CapEx Coverage Ratio | 3.26 | 2.07 | 1.86 | 1.79 | 2.47 |
| Capital Expenditure Coverage Ratio | 11.98 | 6.34 | 5.06 | 7.86 | 7.19 |
| Operating Cash Flow Coverage Ratio | 0.44 | 0.24 | 1.92 | 1.53 | 2.20 |
| Operating Cash Flow to Sales Ratio | 0.33 | 0.20 | 0.19 | 0.16 | 0.23 |
| Free Cash Flow Yield | 4.06% | 1.80% | 2.34% | 2.19% | 2.84% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 31.80 | 47.01 | 41.89 | 49.01 | 39.50 |
| Price-to-Sales (P/S) Ratio | 7.36 | 9.41 | 6.52 | 6.26 | 6.88 |
| Price-to-Book (P/B) Ratio | 4.67 | 6.13 | 4.23 | 3.77 | 4.18 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 24.65 | 55.67 | 42.77 | 45.66 | 35.17 |
| Price-to-Operating Cash Flow Ratio | 22.60 | 46.88 | 34.31 | 39.85 | 30.28 |
| Price-to-Earnings Growth (PEG) Ratio | 1.06 | 1.07 | 0.94 | -1.89 | 1.89 |
| Enterprise Value Multiple | 21.96 | 33.39 | 25.64 | 27.32 | 23.16 |
| Enterprise Value | 1.99B | 2.23B | 1.26B | 1.01B | 1.06B |
| EV to EBITDA | 21.96 | 33.39 | 25.64 | 27.32 | 23.16 |
| EV to Sales | 7.99 | 10.14 | 6.49 | 6.24 | 6.90 |
| EV to Free Cash Flow | 26.77 | 59.98 | 42.59 | 45.54 | 35.23 |
| EV to Operating Cash Flow | 24.53 | 50.51 | 34.17 | 39.75 | 30.33 |
| Tangible Book Value Per Share | 13.01 | 10.49 | 8.56 | 7.09 | 6.40 |
| Shareholders’ Equity Per Share | 17.38 | 15.02 | 13.41 | 12.20 | 12.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.23 | 0.23 | 0.24 | 0.25 | 0.22 |
| Revenue Per Share | 11.03 | 9.79 | 8.71 | 7.36 | 7.30 |
| Net Income Per Share | 2.55 | 1.96 | 1.36 | 0.94 | 1.27 |
| Tax Burden | 0.77 | 0.77 | 0.76 | 0.75 | 0.78 |
| Interest Burden | 0.94 | 1.00 | 1.00 | 1.00 | 0.94 |
| Research & Development to Revenue | 0.06 | 0.07 | 0.09 | 0.08 | 0.08 |
| SG&A to Revenue | 0.39 | 0.38 | 0.16 | 0.18 | 0.17 |
| Stock-Based Compensation to Revenue | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 |
| Income Quality | 1.41 | 1.00 | 1.22 | 1.23 | 1.30 |
Currency in USD

